User menu

Changes in Plasma-renin Activity and Hemodynamics During Vasodilator Therapy in Conscious Dogs With Myocardial-infarction Or Chronic Volume Overload

Bibliographic reference Pouleur, H. ; Engler, RL. ; Link, J. ; Printz, MP. ; Covell, JW.. Changes in Plasma-renin Activity and Hemodynamics During Vasodilator Therapy in Conscious Dogs With Myocardial-infarction Or Chronic Volume Overload. In: European Journal of Clinical Investigation, Vol. 13, no. 4, p. 331-338 (1983)
Permanent URL http://hdl.handle.net/2078.1/56586
  1. Awan N. A., Miller R. R., Mason D. T., Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure, 10.1161/01.cir.57.1.152
  2. Chatterjee K., Parmley W. W., Massie B., Greenberg B., Werner J., Klausner S., Norman A., Oral hydralazine therapy for chronic refractory heart failure, 10.1161/01.cir.54.6.879
  3. Chatterjee K, Circulation, 58, 28 (1978)
  4. COHN JAY N., Chronic Vasodilator Therapy in the Management of Cardiogenic Shock and Intractable Left Ventricular Failure, 10.7326/0003-4819-81-6-777
  5. Franciosa JosephA., Limas ConstantinosJ., Guiha NabilH., Rodriguera Ernesto, Cohn JayN., IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION, 10.1016/s0140-6736(72)90460-6
  6. Miller R. R., Vismara L. A., Zelis R., Amsterdam E. A., Mason D. T., Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance, 10.1161/01.cir.51.2.328
  7. Packer M., Meller J., Medina N., Yushak M., Gorlin R., Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy, 10.1161/01.cir.64.3.506
  8. PETTINGER W. A., CAMPBELL W. B., KEETON K., Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat, 10.1161/01.res.33.1.82
  9. GUTKIN MICHAEL, DAS BODH, CHIN BYOUNG-KWON, MEZEY KALMAN, MODLINGER ROBERT S., Synergistic Effects of Hydralazine and Alpha- or Beta-Adrenergic Blockers: The Role of Plasma Renin Activity, 10.1002/j.1552-4604.1977.tb05644.x
  10. Kaneko Yoshihiro, Ikeda Takao, Takeda Tadanao, Ueda Hideo, Renin Release during Acute Reduction of Arterial Pressure in Normotensive Subjects and Patients with Renovascular Hypertension*, 10.1172/jci105571
  11. SANO T., SAWANOBORI T., Mechanism Initiating Ventricular Fibrillation Demonstrated in Cultured Ventricular Muscle Tissue, 10.1161/01.res.26.2.201
  12. Gauer OH, International Review of Physiology, 9, 145 (1976)
  13. Guyton AC, Circ Res, 24, 1 (1968)
  14. Watkins S, J Clin Invest, 57, 1606 (1976)
  15. Flombaum C. D., Chou S. Y., Porush J. G., Slater P. A., Ferder L. F., Levin D. L., Gadhok R. S., Serial evaluation of the renin-angiotensin-aldosterone system in caval dogs, 10.1161/01.res.42.6.778
  16. Pouleur H., Covell J. W., Ross J., Effects of alterations in aortic input impedance on the force-velocity- length relationship in the intact canine heart, 10.1161/01.res.45.1.126
  17. 17. JO. Davis, and E Braunwald, Mechanisms of salt and water retention in cardiac failure . In: The Myocardium: failure and infarction. N.Y. Hospital Practice, 1970 :80 -9 .
  18. Curtiss C., Cohn J. N., Vrobel T., Franciosa J. A., Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure, 10.1161/01.cir.58.5.763
  19. Higgins CB, J Clin Invest, 51, 715 (1972)
  20. Zucker IH, J Clin Invest, 60, 323 (1977)
  21. LeWinter M, Am J Physiol, 235, H422 (1978)
  22. Printz MP, J Biol Chem, 252, 1654 (1977)
  23. Peart WS, Lloyd AM, Thatcher GN, Lever AF, Payne N, Stone N, Purification of pig renin, 10.1042/bj0990708
  24. Harlan JC, Am J Physiol, 231, 1499 (1967)
  25. Mancia G, International Review of Physiology, 112 (1976)
  26. Thames M. D., Jarecki M., Donald D. E., Neural control of renin secretion in anesthetized dogs. Interaction of cardiopulmonary and carotid baroreceptors, 10.1161/01.res.42.2.237
  27. Gero J, Arch Int Pharmacodyn Ther, 140, 35 (1962)
  28. Ross John, Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function, 10.1016/0033-0620(76)90021-9
  29. Aitchison J. D., Cranston W. I., Priest E. A., THE EFFECTS OF 1-HYDRAZINOPHTHALAZINE ON THE PULMONARY CIRCULATION IN MITRAL DISEASE, 10.1136/hrt.17.4.425
  30. Ablad B., Acta Pharmacol Toxicol, 20, 1 (1963)
  31. FREIS E. D., ROSE J. C., HIGGINS T. F., FINNERTY F. A., KELLEY R. T., PARTENOPE E. A., The Hemodynamic Effects of Hypotensive Drugs in Man: IV. 1-Hydrazinophthalazine, 10.1161/01.cir.8.2.199
  32. Gupta KP, Act Int Pharmacodyn Ther, 155, 84 (1965)
  33. Khatri Ibrahim, Uemura Nobuhiro, Notargiacomo Aldo, Freis Edward D., Direct and reflex cardiostimulating effects of hydralazine, 10.1016/0002-9149(77)90097-2
  34. Pouleur H., Covell J. W., Ross J., Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure, 10.1161/01.cir.61.2.328